Hanxue Zheng

Beyond exhaustion: T cell fitness for next generation of immunotherapy for hematological cancer

T cell-directed immunotherapies have transformed the treatment of hematological malignancies, but durable benefit remains limited by relapse, poor persistence, incomplete immune reconstitution and infection. These outcomes depend not only on target-antigen expression but also on the functional quality of the T cell com...